Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Dermapharm Holding SE
  6. Summary
    DMP   DE000A2GS5D8

DERMAPHARM HOLDING SE

(DMP)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/28/2021 07/29/2021 07/30/2021 08/02/2021 08/03/2021 Date
67.55(c) 66.65(c) 67.45(c) 67.7(c) 69.05(c) Last
85 484 28 355 32 937 30 978 53 701 Volume
+4.89% -1.33% +1.20% +0.37% +1.99% Change
More quotes
Estimated financial data (e)
Sales 2021 990 M 1 175 M 1 175 M
Net income 2021 153 M 182 M 182 M
Net Debt 2021 458 M 543 M 543 M
P/E ratio 2021 24,2x
Yield 2021 2,04%
Sales 2022 1 010 M 1 198 M 1 198 M
Net income 2022 159 M 189 M 189 M
Net Debt 2022 352 M 418 M 418 M
P/E ratio 2022 23,4x
Yield 2022 2,12%
Capitalization 3 718 M 4 407 M 4 409 M
EV / Sales 2021 4,22x
EV / Sales 2022 4,03x
Nbr of Employees 2 311
Free-Float 35,0%
More Financials
Company
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It... 
Sector
Pharmaceuticals
Calendar
09/07Earnings Release
More about the company
Ratings of Dermapharm Holding SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about DERMAPHARM HOLDING SE
07/22DGAP-DD : Dermapharm Holding SE english
DJ
07/14DERMAPHARM : Bionity- Drug manufacturer Dermapharm invests millions in CORAT The..
AQ
07/08CORAT Therapeutics GmbH Announces Partnership with Dermapharm Holding SE as S..
CI
07/07DERMAPHARM : To Acquire 25% Stake In Corat Therapeutics
MT
07/07DERMAPHARM : acquires equity investment in CORAT Therapeutics GmbH
EQ
07/07PRESS RELEASE : Dermapharm Holding SE acquires equity investment in CORAT Therap..
DJ
07/07DGAP-ADHOC : Dermapharm Holding SE acquires equity investment in CORAT Therapeut..
DJ
06/23PRESS RELEASE : Dermapharm Holding SE: Annual General Meeting approves dividend ..
DJ
06/23DERMAPHARM HOLDING SE : Annual General Meeting approves dividend distribution of..
EQ
06/23Dermapharm Holding SE Approves Dividend
CI
05/20DERMAPHARM : Berenberg maintains a Buy rating
MD
05/18GLOBAL MARKETS LIVE : Walmart, Home Depot, Amazon, Sonova, Berkshire Hathaway...
05/18DERMAPHARM : Jefferies remains its Buy rating
MD
05/18PRESS RELEASE : Dermapharm Holding SE: accelerated EBITDA growth in Q1 2021
DJ
05/18DERMAPHARM HOLDING SE : accelerated EBITDA growth in Q1 2021
EQ
More news
News in other languages on DERMAPHARM HOLDING SE
07/28ORIGINAL-RESEARCH : GBC Insider Focus Index (von GBC AG):
07/22DGAP-DD : Dermapharm Holding SE deutsch
07/22Dermapharm Holding SE
07/07Dermapharm Holding SE beteiligt sich anáCORAT Therapeutics GmbH
07/07DERMAPHARM : beteiligt sich anáCORAT Therapeutics GmbH
More news
Analyst Recommendations on DERMAPHARM HOLDING SE
More recommendations
Chart DERMAPHARM HOLDING SE
Duration : Period :
Dermapharm Holding SE Technical Analysis Chart | DMP | DE000A2GS5D8 | MarketScreener
Technical analysis trends DERMAPHARM HOLDING SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 69,05 €
Average target price 81,80 €
Spread / Average Target 18,5%
EPS Revisions
Managers and Directors
Hans-Georg Feldmeier Chief Executive Officer
Hilde Neumeyer Chief Financial & Compliance Officer
Wilhelm Beier Chairman-Supervisory Board
Erwin Kern Deputy Chairman-Supervisory Board
Lothar Maximilian Lanz Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
DERMAPHARM HOLDING SE21.23%4 332
JOHNSON & JOHNSON9.46%453 498
ROCHE HOLDING AG13.88%339 298
PFIZER, INC.19.42%246 075
NOVARTIS AG0.14%225 528
ELI LILLY AND COMPANY46.06%224 166